Dr. Robert J. Heine

• 
  www.reviewofendo.com/articles/0708/review0708_08.php - [Cached Version]
  Published on: 7/1/2008    Last Visited: 9/10/2008  

  ADAG Cochair, Robert J. Heine, MD, PhD, Professor of Diabetology in the Department of Endocrinology at the VU University Medical Center in Amsterdam, Netherlands, and Executive Medical Director of the Diabetes and Endocrine Division of Eli Lilly and Company, said: "It is extremely helpful for health care professionals and patients to be using the same language to discuss glucose goals.As patients sometimes find it difficult to understand the concept of glycated hemoglobin, it will be much easier to have all test results—both those from the lab and those the patient performs—in the same units."
  
  With A1C translated from a difficult-to-understand chemical entity into an easy-to-understand value that relates to the patient's everyday home glucose monitoring, Dr. Heine predicts that eAG will prove to be a valuable education tool.

• 
  www.marketwire.com/mw/release.do?id=865881 - [Cached Version]
  Published on: 6/6/2008    Last Visited: 6/8/2008  

  The implications of using eAG in mg/dl or mmol/L -- the same units that patients use for self-monitoring of blood glucose (SMBG) at home -- were discussed recently by his co-chair, Robert J. Heine, MD, PhD, Professor of Diabetology in the Department of Endocrinology at the VU University Medical Center in Amsterdam, Netherlands, and Executive Medical Director of the Diabetes and Endocrine Division of Eli Lilly and Company.
  
  "It is extremely helpful for health care professionals and patients to be using the same language to discuss glucose goals," said Dr. Heine."Since patients sometimes find it difficult to understand the concept of glycated hemoglobin, it will be much easier to have all test results -- both those from the lab and those the patient performs -- in the same units."
  
  With A1C translated from a difficult-to-understand chemical entity into an easy-to-understand value that relates to the patient's everyday home glucose monitoring, Dr. Heine predicts that eAG will prove to be a valuable education tool.
  
  "When health care professionals set goals based on eAG units, then patients will know how close they are to reaching their goals every day when they test at home with self-monitoring," said Dr. Heine.

• 
  www.cmediabetes.com/pub/prof..robert.j..heine.php - [Cached Version]
  Published on: 4/15/2005    Last Visited: 10/22/2008  

  Prof. Robert J. Heine
  ...
  Prof. Robert J. Heine
  
  VU University Medical Center

• 
  sstrumello.blogspot.com/2007/11/business-of-diabetes-si - [Cached Version]
  Published on: 11/16/2007    Last Visited: 12/1/2007  

  This summer, Lilly hired Dr. Robert J. Heine to manage Lilly's diabetes business.But as I noted in September, the selection of Dr. Heine was not a terribly logical choice to manage this business.Dr. Heine's primary research interests and expertise is in the epidemiology and pathophysiology of type 2 diabetes, not type 1 diabetes.
  ...
  Okay, Sidney Taurel (Eli Lilly and Company's Chairman and CEO), as well as Dr. Robert J. Heine, M.D.

• 
  www.diabetesonestop.com/diabetes/t001/diabetesh/1,1201, - [Cached Version]
  Published on: 1/27/2002    Last Visited: 1/27/2002  

  Dr Robert J Heine
  
  Vrije Universiteit Medical Centre

• 
  www.contractpharma.com/news/2007/09/19/executive_moves% - [Cached Version]
  Published on: 9/19/2007    Last Visited: 9/19/2007  

  Robert J. Heine, M.D., Ph.D., F.R.C.P., will join Eli Lilly and Co. in January, 2008, as executive medical director for the diabetes and endocrine division responsible for development of Lilly's expanding diabetes and obesity R&D portfolio.Dr. Heine replaces Dr. Meng Hee Tan, who will retire at the end of September after 8 years of service to the company.
  ...
  "Robert is widely recognized and respected in the diabetes community for his scientific and clinical excellence and his considerable leadership abilities.He'll be a fantastic addition to the Lilly team."
  
  Dr. Heine is currently professor of diabetology in the Department of Endocrinology and director of the Diabetes Centre at the VU (Vrije Universiteit) University Medical Center in Amsterdam, Netherlands.He also holds positions within the European Association for the Study of Diabetes (EASD), the European Foundation for the Study of Diabetes (EFSD) and the American Diabetes Association (ADA), including chair of the EASD subcommittee for Clinical Research Training, president of the organizing committee for the 2007 EASD annual meeting, and a member of the ADA Expert Committee on guidelines for the treatment of hyperglycemia in type 2 diabetes.Dr. Heine's primary research interests include the epidemiology and pathophysiology of type 2 diabetes.

• 
  www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/w - [Cached Version]
  Published on: 9/18/2007    Last Visited: 9/18/2007  

  Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
  ...
  INDIANAPOLIS, Sept. 18 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced that Robert J. Heine, M.D., Ph.D., F.R.C.P., will join Lilly in January, 2008, as Executive Medical Director for the Diabetes and Endocrine division responsible for development of Lilly's expanding diabetes and obesity R&D portfolio.Dr. Heine replaces Dr. Meng
  ...
  "Robert is widely recognized and respected in the diabetes community for his scientific and clinical excellence and his considerable leadership abilities.He'll be a fantastic addition to the Lilly team." Heine is currently professor of diabetology in the Department of Endocrinology and director of the Diabetes Centre at the VU (Vrije Universiteit) University Medical Center in Amsterdam, Netherlands.In addition to involvement in several research projects, Heine holds positions within the European Association for the Study of Diabetes (EASD), the
  ...
  Heine's primary research interests include the epidemiology and pathophysiology of type 2 diabetes. "We couldn't be more pleased that Dr. Heine has decided to bring his
  ...
  Heine.

• 
  investors.amylin.com/phoenix.zhtml?c=101911&p=irol-news - [Cached Version]
  Published on: 8/21/2003    Last Visited: 9/21/2008  

  The chair of the event is Prof. Robert Heine, MD, PhD, of Vrije Universiteit Med Center in the Netherlands.Presentations will be given by Dr. Heine, Dr. Ralph DeFronzo, Professor of Medicine at the University of Texas in the United States, Dr. Jay Skyler, Professor of Medicine, Pediatrics & Psychology at the University of Miami in the United States and Prof. Michael Nauck, MD from Diabeteszentrum Bad Lauterberg in Germany.

• 
  dominoext.novartis.com/NC/NCMediaRel9798.nsf/a5f5b63dbc - [Cached Version]
  Published on: 4/5/2001    Last Visited: 1/7/2004  

  "Starlix stimulates early phase insulin secretion, the body's first defense against mealtime glucose spikes," explained Professor Robert Heine, Director of the Diabetes Center, Vrije Universiteit Medical Center, Amsterdam.

• 
  www.dlife.com/diabetes-news/blood_sugar/ - [Cached Version]
  Last Visited: 8/26/2008  

  of blood glucose (SMBG) at home - were discussed recently by his co-chair, Robert J. Heine, MD, PhD, Professor of Diabetology in the Department of Endocrinology at the VU University Medical Center in Amsterdam, Netherlands, and Executive Medical Director of the Diabetes and Endocrine Division of Eli Lilly and Company.
  
  "It is extremely helpful for health care professionals and patients to be using the same language to discuss glucose goals," said Dr. Heine."Since patients sometimes find it difficult to understand the concept of glycated hemoglobin, it will be much easier to have all test results - both those from the lab and those the patient performs - in the same units."
  
  With A1C translated from a difficult-to-understand chemical entity into an easy-to-understand value that relates to the patient's every day home glucose monitoring, Dr. Heine predicts that eAG will prove to be a valuable education tool.
  
  "When health care professionals set goals based on eAG units, then patients will know how close they are to reaching their goals every day when they test at home with self-monitoring," said Dr. Heine.

Page:  1 2 3 4